| Name | Steward Organization | Suggested Domain | Suggested Domain Description | Cde Group | Classification |
|---|---|---|---|---|---|
| PhenX - gastroesophageal reflux disease (GERD) symptoms protocol 191101 | NICHD | Disease characterization |
Including Alzheimer's Disease (AD)/AD-Related Dementias (ADRD) diagnosis and multiple chronic conditions (MCCs) |
NIH CDEs |
|
| # | Datatype |
|---|---|
|
|
Text |
| # | Definition | Tags |
|---|---|---|
|
|
The Gastroesophageal Reflux Disease Questionnaire (GerdQ) is a 6-item questionnaire that helps identify patients with gastroesophageal reflux disease (GERD). Patients are asked to report frequency of symptoms over the past 7 days. If the administration of the GerdQ produces a positive score for GERD, the Gastrointestinal Working Group (WG) recommends performing a pH impedence test to confirm the results and determine disease severity. Please see the Gastrointestinal WG Supplemental Information for a pH impedence test protocol. The Gastroesophageal Reflux Disease Questionnaire (GerdQ) is a proprietary instrument that is available for use with permission from AstraZeneca. To obtain permission, contact AstraZeneca at PROinformation@astrazeneca.com and complete a License Agreement. | Source: Regenstrief LOINC |
| # | Designation | Tags |
|---|---|---|
|
|
Are there symptoms or signs of gastrointestinal reflux? | |
|
|
PhenX - gastroesophageal reflux disease (GERD) symptoms protocol 191101 | Long Common Name |
|
|
GERD symptoms proto | Short Name |
| # | Identifier | Origin | Version |
|---|---|---|---|
|
|
62973-3 | LOINC | 2.69 |
|
|
pv_ger | NICHD Variable Name | N/A |
|
|
bhhA_i_2Tt | NLM CDEs | 12-02-2025-download |